| Literature DB >> 28700815 |
Pamina Contreras-Kallens1, Claudia Terraza1, Karina Oyarce1, Tania Gajardo1, Mauricio Campos-Mora1, María Teresa Barroilhet1, Carla Álvarez1, Ricardo Fuentes1, Fernando Figueroa1, Maroun Khoury1,2,3, Karina Pino-Lagos1.
Abstract
Since they were first described, mesenchymal stem cells (MSCs) have been shown to have important effector mechanisms and the potential for use in cell therapy. A great deal of research has been focused on unveiling how MSCs contribute to anti-inflammatory responses, including describing several cell populations involved and identifying soluble and other effector molecules. In this review, we discuss some of the contemporary evidence for use of MSCs in the field of immune tolerance, with a special emphasis on transplantation. Although considerable effort has been devoted to understanding the biological function of MSCs, additional resources are required to clarify the mechanisms of their induction of immune tolerance, which will undoubtedly lead to improved clinical outcomes for MSC-based therapies.Keywords: MSC; T cells; immunosuppression; therapy; tolerance; transplantation
Mesh:
Year: 2017 PMID: 28700815 DOI: 10.1111/nyas.13364
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691